Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Effects and tolerance of silymarin (milk thistle) in chronic hepatitis C virus infection patients: a meta-analysis of randomized controlled trials.

Yang Z, Zhuang L, Lu Y, Xu Q, Chen X.

Biomed Res Int. 2014;2014:941085. doi: 10.1155/2014/941085. Epub 2014 Aug 27. Review.

2.

Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection.

Polyak SJ, Ferenci P, Pawlotsky JM.

Hepatology. 2013 Mar;57(3):1262-71. doi: 10.1002/hep.26179. Review. No abstract available.

3.

Hepatitis C virus and natural compounds: a new antiviral approach?

Calland N, Dubuisson J, Rouillé Y, Séron K.

Viruses. 2012 Oct 17;4(10):2197-217. doi: 10.3390/v4102197. Review.

4.

Hepatitis C viral kinetics: the past, present, and future.

Chatterjee A, Smith PF, Perelson AS.

Clin Liver Dis. 2013 Feb;17(1):13-26. doi: 10.1016/j.cld.2012.09.003. Review.

5.

Silymarin for HCV infection.

Polyak SJ, Oberlies NH, Pécheur EI, Dahari H, Ferenci P, Pawlotsky JM.

Antivir Ther. 2013;18(2):141-7. doi: 10.3851/IMP2402. Epub 2012 Sep 25. Review.

6.

Hepatitis C therapy in non-genotype 1 patients: the near future.

Wartelle-Bladou C, Le Folgoc G, Bourlière M, Lecomte L.

J Viral Hepat. 2012 Aug;19(8):525-36. doi: 10.1111/j.1365-2893.2012.01634.x. Review.

PMID:
22762136
7.

Immunosuppression, liver injury and post-transplant HCV recurrence.

Ciesek S, Wedemeyer H.

J Viral Hepat. 2012 Jan;19(1):1-8. doi: 10.1111/j.1365-2893.2011.01548.x. Epub 2011 Nov 7. Review.

PMID:
22187942

Supplemental Content

Loading ...
Support Center